Author: OurCrowd

[Alloy Therapeutics in Business Wire] Alloy Therapeutics expands executive team to strengthen therapeutic discovery and innovation for its partners

BOSTON–(BUSINESS WIRE)–Alloy Therapeutics, a biotechnology ecosystem company, announced expanded leadership to strengthen its portfolio of drug discovery capabilities and technologies for the global scientific community. Michael Schmidt, PhD has joined the company as its Chief Scientific Officer (CSO), where he will oversee technical innovation and ensure high scientific quality for Alloy’s broad portfolio of platforms, services, and venture studio company creation. Alloy has promoted Martin Leach, PhD, MBA to Chief Operating Officer (COO), from his previous position of Alloy Senior Vice President of Global Informatics and COO of its Daedamab research facility. Read...

Read More

[Quantum Machines in PR Newswire] Quantum Machines forges strategic partnerships with leading korean research and investment groups Français

SEOUL, South Korea and TEL AVIV, Israel, June 28, 2023 /PRNewswire/ — Quantum Machines, the world’s leading provider of quantum control systems, is pleased to announce the signing of three significant Memorandums of Understanding (MOUs) with prominent Korean research and investment organizations. The MOUs, signed with the Korea Research Institute of Standards and Science (KRISS), Korea Quantum Computing Industry Leaders’ Alliance (QCILA), and Orientom, will foster collaboration and strengthen the relationship between local Korean researchers, Quantum Machines, and the Israeli Quantum Computing Center (QCC), which is being developed and managed by Quantum Machines. Read more...

Read More